Guifang Xie

NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells

Zhiyun Yu, Guifang Xie, Guangtong Zhou et al. · Cancer Letters · 2015 · 114 citations

Neuro-oncology, Human Glioma Cells, Medicine +7

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells<i>in vitro</i>and<i>in vivo</i>

Zhiyun Yu, Gang Zhao, Guifang Xie et al. · Oncotarget · 2015 · 100 citations · Full text

Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells

Zhiyun Yu, Gang Zhao, Pengliang Li et al. · Oncology Letters · 2016 · 53 citations · Full text

Dual blocking of PI3K and mTOR signaling by NVP-BEZ235 inhibits proliferation in cervical carcinoma cells and enhances therapeutic response

Guifang Xie, Zhaoyong Wang, Yong Chen et al. · Cancer Letters · 2016 · 39 citations

Cervical Carcinoma Cells, Signaling Pathway, Cervical Cancer +9

<scp>LncRNA‐mediated ceRNA</scp> network was identified as a crucial determinant of differential effects in periodontitis and periimplantitis by high‐throughput sequencing

Hailun Zhou, Donghui Chen, Guifang Xie et al. · Clinical Implant Dentistry and Related Research · 2020 · 38 citations